mCannabis

For research organizations in Alberta working at the intersection of healthcare, biotechnology, and cannabis science, closing evidence gaps around medical cannabis remains a pressing challenge. The mCannabis program from Alberta Innovates is designed to support research that advances understanding of how cannabis-based compounds may be used safely and effectively in medical settings, particularly in the area of pain management where unmet needs remain high.

Rather than focusing on commercialization or consumer products, mCannabis places its emphasis on pre-clinical research and knowledge development. Projects typically explore the biological effects of cannabis-derived chemicals, including lesser-studied cannabinoids and terpenoids, with the goal of generating credible scientific insights that can inform future medical applications. Funding is provided as non-repayable support and is tailored to the scope and potential impact of each project, making it especially relevant for nonprofits and research-focused organizations pursuing early-stage or exploratory work.

Applications are assessed through a structured review process that considers scientific merit, innovation potential, and the strength of the research plan, with input from both internal experts and external reviewers. While program intakes are not always open, organizations interested in cannabis-based medical research may want to keep mCannabis on their radar and explore whether upcoming opportunities align with their research objectives.